D
Donald F. Newgreen
Researcher at Royal Children's Hospital
Publications - 160
Citations - 11611
Donald F. Newgreen is an academic researcher from Royal Children's Hospital. The author has contributed to research in topics: Neural crest & Enteric nervous system. The author has an hindex of 57, co-authored 159 publications receiving 10493 citations. Previous affiliations of Donald F. Newgreen include Australian Regenerative Medicine Institute & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Guidelines and definitions for research on epithelial–mesenchymal transition
Jing Yang,Parker B. Antin,Geert Berx,Cédric Blanpain,Thomas Brabletz,Marianne E. Bronner,Kyra Campbell,Amparo Cano,Jordi Casanova,Gerhard Christofori,Shoukat Dedhar,Rik Derynck,Heide L. Ford,Jonas Fuxe,Antonio García de Herreros,Gregory J. Goodall,Anna-Katerina Hadjantonakis,Ruby Yun-Ju Huang,Chaya Kalcheim,Raghu Kalluri,Yibin Kang,Yeesim Khew-Goodall,Herbert Levine,Jinsong Liu,Gregory D. Longmore,Sendurai A. Mani,Joan Massagué,Roberto Mayor,David R. McClay,Keith E. Mostov,Donald F. Newgreen,M. Angela Nieto,Alain Puisieux,Alain Puisieux,Raymond B. Runyan,Pierre Savagner,Ben Z. Stanger,Marc P. Stemmler,Yoshiko Takahashi,Masatoshi Takeichi,Eric Theveneau,Jean Paul Thiery,Erik W. Thompson,Robert A. Weinberg,Elizabeth D. Williams,Jianhua Xing,Binhua P. Zhou,Guojun Sheng +47 more
TL;DR: This Consensus Statement is the outcome of a 2-year-long discussion among EMT researchers and aims to both clarify the nomenclature and provide definitions and guidelines for EMT research in future publications to reduce misunderstanding and misinterpretation of research data generated in various experimental models.
Journal ArticleDOI
Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition?
TL;DR: A key clinical turning point in carcinoma progression is the establishment by emigrant cells of secondary growth sites (i.e., metastasis) as discussed by the authors, which leads to dysregulation of the normal control of cell number.
Journal ArticleDOI
The fallacy of epithelial mesenchymal transition in neoplasia.
TL;DR: It is concluded that there is no convincing evidence for conversion of epithelial cells into mesenchymal cell lineages in vivo and that the biological repertoire of normal and malignant cells is sufficient to account for the events and processes observed, without needing to invoke radical changes in cell identity.
Journal ArticleDOI
Fibronectin in early avian embryos: Synthesis and distribution along the migration pathways of neural crest cells
TL;DR: Immunoperoxidase labelling for fibronectin in chick embryos showed FN-positive basement membranes surrounding the neural crest cell population prior to crest-cell migration, which may be the first expression of mesenchymal differentiation in these crest cells and in vivo enable them to occupy a large space.
Vimentin and epithelial-mesenchymal transition in human breast cancer : observations in vitro and in vivo
Maria I Kokkinos,Razan Wafai,Meng Kang Wong,Donald F. Newgreen,Erik W. Thompson,Erik W. Thompson,Mark Waltham,Mark Waltham +7 more
TL;DR: In this article, a review summarises observations of vimentin expression in breast cancer model systems, and discusses the potential role of EMT in human breast cancer progression, and the prognostic usefulness of VIGIN expression.